Dr's Eye Vision
Natural health product licensed in Canada
- Licence holder
- Rapha Canadian Natural
- NPN or DIN-HM
- 80107784
- Status
- Active licence
- Licence date
- 2 February 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 50 mg | Not calculated |
| Tagetes erecta Source : Fleur Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,100 mg Potency : 20 mg Lutein esters | 220 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg Potency : 25 % Anthocyanins | 25 mg | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 390 mcg EAR | Not calculated |
| Zinc Source : Citrate de zinc | 3 mg | 6,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80107784
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.